Skip to content
ForsøksdyrkomitéenNorsk

International medicines regulators aim to replace animal testing

Nyhet

Medicines regulators from around the world have come together in a joint statement to promote the development and use of animal-free methods. The aim is to reduce and eventually replace animal testing in the development, approval and control of medicines.

The statement was published on 1 October 2026 by the International Coalition of Medicines Regulatory Authorities (ICMRA), an international collaboration between medicines regulators. It was prepared by the medicines regulators of the EU, the United Kingdom, Ireland and Switzerland and adopted by ICMRA.

The regulators encourage the pharmaceutical industry to adopt scientifically reliable animal-free methods as soon as possible. They also ask national authorities to facilitate this through regulatory changes and international cooperation.

There is particularly great potential for replacing animal testing in the routine quality control of medicines. Here, ICMRA considers that animal testing should only be approved if it can be documented that no equally good or better animal-free methods are available.

The statement is not legally binding and contains no specific deadlines. Nevertheless, it is an important international signal from the authorities that themselves set the requirements for documenting the safety and quality of medicines. If animal-free methods are to be used more widely, the authorities’ requirements and approval practice must also make this possible.